TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive NCI, Groups Disagree Over repayment, McIntyre: NCA Could Examine Relationship of Groups To NCI December 9, 1994
TCL Archive Funding Opportunity: NYC-based Research Alliance Offering $200,000 Per Year for Young Investigators October 3, 2014
TCL Archive New RFAs Released: Kaposi Sarcoma; Rare Tumors; Biochemical Epidemiology; Dietary Questionnaire; Role of Nicotine August 20, 1982
